APTAH
Summary of public USPTO data
- Owner
- Aptah Bio Inc.
- Status
- Live/Registered
- Serial number
- 97041301
- Registration number
- 8345887
- Filing date
- 2021-09-23
- Registration date
- 2026-07-14
- International classes
- 1, 5, 42
Goods and services
Class 1
- Biomolecules in the nature of gene therapy products, namely, genetically engineered stem cells in the nature of synthetic cDNAs for controlling gene expression for medical and scientific research
Class 5
- Pharmaceutical preparations for the configuration, modulation and correction of RNA transcript splicing, capping and tailing for the treatment of genetic diseases
- pharmaceutical preparations for the configuration, modulation and correction of RNA for the treatment of genetic diseases
- pharmaceutical preparations for restoring and reprograming RNA-protein interactions for the treatment of genetic diseases
- pharmaceutical preparations for the treatment of genetic diseases associated with gene dysregulation, inhibition or suppression of gene expression
- pharmaceutical preparations for the treatment of genetic diseases
- gene therapy products, namely, molecules in the nature of genetically engineered tissues for controlling gene expression
- medical molecular diagnostic tests for testing bodily fluid for the detection of genetic diseases
- medical diagnostic tests for the detection of neurodegenerative, oncological and infectious diseases
Class 42
- Research and development of pharmaceuticals, namely, therapies for the configuration, modulation and correction of RNA transcript splicing, capping and tailing
- scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, DNA, RNA, molecules and proteins
- pharmaceutical products design and development in the field of biomolecules for medical and scientific use, and medical treatment
- pharmaceutical drug design and development featuring biomolecules